BG105010A - Medicamentous form containing paroxetine - Google Patents

Medicamentous form containing paroxetine

Info

Publication number
BG105010A
BG105010A BG105010A BG10501000A BG105010A BG 105010 A BG105010 A BG 105010A BG 105010 A BG105010 A BG 105010A BG 10501000 A BG10501000 A BG 10501000A BG 105010 A BG105010 A BG 105010A
Authority
BG
Bulgaria
Prior art keywords
form containing
containing paroxetine
medicamentous form
medicamentous
paroxetine
Prior art date
Application number
BG105010A
Other languages
Bulgarian (bg)
Inventor
David Elder
Graham LEONARD
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of BG105010A publication Critical patent/BG105010A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Paroxetine hydrochloride, in a form other than hemihydrate, which is formulated into tablets under conditions such that there is no detectable conversion to hemihydrate during the tabletting process. 9 claims
BG105010A 1998-05-13 2000-11-30 Medicamentous form containing paroxetine BG105010A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9810181.9A GB9810181D0 (en) 1998-05-13 1998-05-13 Novel formulations
PCT/GB1999/001520 WO1999058113A2 (en) 1998-05-13 1999-05-13 Novel formulation containing paroxetine

Publications (1)

Publication Number Publication Date
BG105010A true BG105010A (en) 2001-07-31

Family

ID=10831927

Family Applications (1)

Application Number Title Priority Date Filing Date
BG105010A BG105010A (en) 1998-05-13 2000-11-30 Medicamentous form containing paroxetine

Country Status (20)

Country Link
EP (1) EP1077682A2 (en)
JP (1) JP2002514591A (en)
KR (1) KR20010043574A (en)
CN (1) CN1308521A (en)
AP (1) AP2000002019A0 (en)
AU (1) AU3940999A (en)
BG (1) BG105010A (en)
BR (1) BR9910401A (en)
CA (1) CA2331871A1 (en)
EA (1) EA200001174A1 (en)
GB (1) GB9810181D0 (en)
HU (1) HUP0102064A2 (en)
ID (1) ID28019A (en)
IL (1) IL139594A0 (en)
NO (1) NO20005683L (en)
PL (1) PL344573A1 (en)
SK (1) SK17142000A3 (en)
TR (1) TR200003350T2 (en)
WO (1) WO1999058113A2 (en)
ZA (1) ZA200006562B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0003232D0 (en) * 2000-02-11 2000-04-05 Smithkline Beecham Plc Novel composition
CA2359812C (en) 2000-11-20 2004-02-10 The Procter & Gamble Company Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
HUP0401895A2 (en) * 2001-10-22 2004-12-28 Synthon B.V. N-formyl derivatives of paroxetine, process for their preparation and pharmaceutical compositions containing them

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9325644D0 (en) * 1993-12-15 1994-02-16 Smithkline Beecham Plc Novel formulation
US5672612A (en) * 1996-09-09 1997-09-30 Pentech Pharmaceuticals, Inc. Amorphous paroxetine composition
NZ336587A (en) * 1997-01-15 2001-01-26 Smithkline Beecham P Spray dried paroxetine compositions using organic solvent selected from pyridine, acetic acid, acetonitrile, acetone, ethanol, propan-1-ol or tetrahydrofuran
NZ505123A (en) * 1997-12-19 2003-07-25 Smithkline Beecham Corp Process for manufacturing bite-dispersion tablets by compressing medicaments and other ingredients into granulates then compressing the granulates and other ingredients into tablets, and the tablets thereof

Also Published As

Publication number Publication date
EA200001174A1 (en) 2001-06-25
WO1999058113A3 (en) 2000-02-17
IL139594A0 (en) 2002-02-10
ZA200006562B (en) 2002-02-13
GB9810181D0 (en) 1998-07-08
SK17142000A3 (en) 2001-06-11
TR200003350T2 (en) 2001-03-21
BR9910401A (en) 2001-01-09
CA2331871A1 (en) 1999-11-18
AP2000002019A0 (en) 2000-12-31
KR20010043574A (en) 2001-05-25
EP1077682A2 (en) 2001-02-28
WO1999058113A2 (en) 1999-11-18
CN1308521A (en) 2001-08-15
ID28019A (en) 2001-05-03
HUP0102064A2 (en) 2002-05-29
PL344573A1 (en) 2001-11-05
NO20005683D0 (en) 2000-11-10
JP2002514591A (en) 2002-05-21
AU3940999A (en) 1999-11-29
NO20005683L (en) 2000-12-05

Similar Documents

Publication Publication Date Title
NZ507271A (en) Fast disintegrating tablets
CA2257303A1 (en) Biconvex rapidly disintegrating dosage forms
MY135183A (en) Rapidly disintegrating methylcellulose tablets
EP1047407A4 (en) Process for manufacturing bite-dispersion tablets
HU227841B1 (en) 2-phenyl substituted imidazotriazinones, process for their preparation and pharmaceutical compositions thereof
HUP0002248A3 (en) Tablets, and process for making tablets
MX9801890A (en) Novel human nk3 receptor-selective antagonist compounds, method for obtaining them and pharmaceutical compositions containing them.
TW200716550A (en) Pharmaceutical composition comprising ritonavir
GB8906414D0 (en) Solid,rapidly disintegrating dosage form
CA2433366A1 (en) Amlodipine free base
BG105011A (en) Composition containing paroxetine
BG105010A (en) Medicamentous form containing paroxetine
BG103650A (en) Method for the preparation of eprosartan
HK1029025A1 (en) Compressed chloramine-t tablets and method for the production thereof
EP1044394A4 (en) Process for preparing a radiation-sensitive composition
EP0178299A4 (en) Sustained release oral dosage form for naproxyn.
CZ20022240A3 (en) Mannich bases of substituted 1-a 2-naphthol
IL148161A0 (en) Process for the preparation of 2-cyanopyridines
IT8820347A0 (en) PRESS FOR CERAMIC SHAPED PIECES, ESPECIALLY TILES.
BG102638A (en) Tablets having increased phamcyclovir content
EP0587566A4 (en) Process for massive conversion of clostridia into synchronized cells of critical length or refractile endospores.
IT1293292B1 (en) DEVICE FOR SINGULARIZED FEEDING OF ARTICLES TO RECEIVING BODIES UNDERLYING.
IT1269361B (en) PRESS, IN PARTICULAR FOR CERAMIC TILES
EP0949921A4 (en)
HUP0203655A3 (en) Unsaturated 14,15-cyclopropane-androstanes, a method for their production and pharmaceutical compositions containing these compounds